• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物治疗与制剂的进展。

Advances in opioid therapy and formulations.

作者信息

Walsh Declan

机构信息

The Harry R. Horvitz Center for Palliative Medicine, The Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA.

出版信息

Support Care Cancer. 2005 Mar;13(3):138-44. doi: 10.1007/s00520-004-0743-x. Epub 2004 Dec 14.

DOI:10.1007/s00520-004-0743-x
PMID:15599600
Abstract

Newly developed opioid analgesics and drug delivery systems may provide pain relief for patients intolerant of morphine. Long-acting oral opioids supply satisfactory analgesia at more convenient dosing intervals. Implantable pumps can provide full analgesic doses of opioids both subcutaneously and intrathecally over extended time periods. Optimal opioid use should rely on individualized dose-finding approaches to enhance pain relief while limiting drug-related side effects and avoiding the common problems associated with opioid prescription in clinical practice.

摘要

新研发的阿片类镇痛药和给药系统可能为不耐受吗啡的患者提供疼痛缓解。长效口服阿片类药物在更方便的给药间隔下提供令人满意的镇痛效果。植入式泵可在较长时间段内皮下和鞘内提供全剂量的阿片类镇痛药。最佳的阿片类药物使用应依赖个体化的剂量确定方法,以增强疼痛缓解效果,同时限制药物相关副作用,并避免临床实践中与阿片类药物处方相关的常见问题。

相似文献

1
Advances in opioid therapy and formulations.阿片类药物治疗与制剂的进展。
Support Care Cancer. 2005 Mar;13(3):138-44. doi: 10.1007/s00520-004-0743-x. Epub 2004 Dec 14.
2
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.缓释口服吗啡与透皮芬太尼及口服美沙酮在癌症疼痛管理中的比较
Eur J Pain. 2008 Nov;12(8):1040-6. doi: 10.1016/j.ejpain.2008.01.013. Epub 2008 Mar 18.
3
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
4
Randomized clinical trial of an implantable drug delivery system.
J Clin Oncol. 2003 Jul 15;21(14):2800-1; author reply 2802-3. doi: 10.1200/JCO.2003.99.003.
5
[The opioid combination of transdermal fentanyl and sustained release morphine for refractory cancer pain--a case report].[透皮芬太尼与缓释吗啡联合用于难治性癌痛的病例报告]
Gan To Kagaku Ryoho. 2005 Nov;32(12):1997-2000.
6
[Parenteral opioids in end-of-life care in cancer patients].[癌症患者临终关怀中的胃肠外阿片类药物]
Gan To Kagaku Ryoho. 2005 Feb;32(2):161-6.
7
Nurse-controlled analgesia using a patient-controlled analgesia device: an alternative strategy in the management of severe cancer pain in children.
J Paediatr Child Health. 1997 Aug;33(4):352-5. doi: 10.1111/j.1440-1754.1997.tb01616.x.
8
Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol.使用缓释羟考酮和即释吗啡进行阿片类药物滴定治疗中度/重度癌痛:CoDem方案的初步评估
J Opioid Manag. 2014 Jan-Feb;10(1):29-38. doi: 10.5055/jom.2014.0189.
9
Management of cancer-related pain with transdermal fentanyl.透皮芬太尼用于癌症相关疼痛的管理
J Med Assoc Thai. 1996 Jun;79(6):341-6.
10
Controlled-release oxycodone.控释羟考酮
J Am Acad Orthop Surg. 2005 Jan-Feb;13(1):1-4. doi: 10.5435/00124635-200501000-00001.

引用本文的文献

1
Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline.阿片类镇痛药剂量和给药途径换算比研究:一项范围综述,为电子德尔菲指南提供信息。
Support Care Cancer. 2024 Jul 24;32(8):542. doi: 10.1007/s00520-024-08710-0.
2
Effects of different electroacupuncture scheduling regimens on murine bone tumor-induced hyperalgesia: sex differences and role of inflammation.不同电针方案对鼠骨肿瘤诱导痛觉过敏的影响:性别差异和炎症的作用。
Evid Based Complement Alternat Med. 2012;2012:671386. doi: 10.1155/2012/671386. Epub 2012 Dec 20.
3
Pharmacological management of cancer pain in the elderly.

本文引用的文献

1
Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study.控释羟考酮与控释吗啡治疗癌痛的比较:一项随机、双盲、平行组研究。
Eur J Pain. 1998;2(3):239-49. doi: 10.1016/s1090-3801(98)90020-9.
2
Oxymorphone--Endo/Penwest: EN 3202, EN 3203.羟吗啡酮——安度/彭韦斯特公司:EN 3202,EN 3203。
Drugs R D. 2003;4(3):204-6. doi: 10.2165/00126839-200304030-00012.
3
Opioids in cancer pain: common dosing errors.
老年人癌症疼痛的药物治疗
Drugs Aging. 2007;24(9):761-76. doi: 10.2165/00002512-200724090-00004.
Oncology (Williston Park). 2003 Apr;17(4):571-5; discussion 575-6, 579.
4
Variations in patients' self-report of pain by treatment setting.
J Pain Symptom Manage. 2003 May;25(5):444-8. doi: 10.1016/s0885-3924(03)00077-0.
5
Opioid equianalgesic conversion: the right dose.阿片类药物等效镇痛转换:正确剂量
Clin J Oncol Nurs. 2001 Jul-Aug;5(4):163-5.
6
Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.控释羟考酮用于治疗糖尿病性神经病变疼痛:一项随机对照试验。
Neurology. 2003 Mar 25;60(6):927-34. doi: 10.1212/01.wnl.0000057720.36503.2c.
7
Visual analog pain scores do not define desire for analgesia in patients with acute pain.
Acad Emerg Med. 2003 Mar;10(3):211-4. doi: 10.1111/j.1553-2712.2003.tb01992.x.
8
Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.普通释放型和控释型羟考酮:药代动力学、药效学及争议
Support Care Cancer. 2003 Feb;11(2):84-92. doi: 10.1007/s00520-002-0385-9. Epub 2002 Aug 23.
9
Clinical pharmacology of opioids for pain.用于疼痛治疗的阿片类药物的临床药理学
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13. doi: 10.1097/00002508-200207001-00002.
10
Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.可植入药物输送系统与难治性癌痛综合药物治疗对比的随机临床试验:对疼痛、药物相关毒性及生存的影响
J Clin Oncol. 2002 Oct 1;20(19):4040-9. doi: 10.1200/JCO.2002.02.118.